Related Experiment Video
Updated: Jun 6, 2026
Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling
Published on: April 3, 2026
Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention
Bjørn Skogen1, Mette Kjær Killie, Jens Kjeldsen-Kragh
1Laboratory Medicine, University Hospital of North Norway, N-9038 Tromsø, Norway. bjorn.skogen@unn.no
Insights
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) understanding has improved with new prospective studies. These findings are guiding better diagnostics, prevention, and treatment for this serious condition in mothers and infants.
Area of Science:
- Perinatology
- Immunology
- Hematology
Background:
- Fetal and neonatal alloimmune thrombocytopenia (FNAIT) pathophysiology remains unclear, complicating management.
- Retrospective data limits understanding of FNAIT's natural history.
- Lack of reliable risk factors and effective treatments has prevented widespread FNAIT screening.
Purpose of the Study:
- To re-evaluate the understanding of FNAIT pathophysiology.
- To improve diagnostics, prevention, and treatment strategies for FNAIT.
Main Methods:
- Prospective screening studies involving up to 100,000 pregnant women were analyzed.
- Data from these studies were used to reassess FNAIT pathophysiology.
Main Results:
- New prospective studies have significantly advanced the understanding of FNAIT pathophysiology.
- This improved understanding facilitates a more appropriate approach to FNAIT management.
Conclusions:
- Prospective studies have enhanced the comprehension of FNAIT.
- This progress supports better diagnostic, preventive, and therapeutic strategies for affected mothers and neonates.
Abstract:
Uncertainty regarding the pathophysiology of fetal and neonatal alloimmune thrombocytopenia (FNAIT) has hampered the decision regarding how to identify, follow-up and treat the women and children with this potentially serious condition. Since knowledge of the condition is derived mainly from retrospective studies, understanding of the natural history of this condition remains incomplete. General screening programs for FNAIT have still not been introduced, mainly because of a lack of reliable risk factors and effective treatment. Now, several prospective screening studies involving up to 100,000 pregnant women have been published and the results have changed the understanding of the pathophysiology of FNAIT and, thereby, the approach toward diagnostics, prevention and treatment in a more appropriate way.
Related Concept Videos
01:19Rh Blood Group
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...